14.36
Schlusskurs vom Vortag:
$14.04
Offen:
$13.81
24-Stunden-Volumen:
374.39K
Relative Volume:
1.05
Marktkapitalisierung:
$596.04M
Einnahmen:
$150.71M
Nettoeinkommen (Verlust:
$-40.85M
KGV:
-14.22
EPS:
-1.01
Netto-Cashflow:
$-25.98M
1W Leistung:
+2.32%
1M Leistung:
-20.75%
6M Leistung:
+5.59%
1J Leistung:
-7.77%
Si Bone Inc Stock (SIBN) Company Profile
Firmenname
Si Bone Inc
Sektor
Branche
Telefon
(408) 207-0700
Adresse
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Vergleichen Sie SIBN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SIBN
Si Bone Inc
|
14.36 | 596.04M | 150.71M | -40.85M | -25.98M | -1.01 |
![]()
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-06 | Bestätigt | Needham | Buy |
2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
2022-10-12 | Eingeleitet | Jefferies | Buy |
2022-04-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2021-06-08 | Eingeleitet | Citigroup | Buy |
2021-03-09 | Bestätigt | Needham | Buy |
2020-12-16 | Bestätigt | Needham | Buy |
2020-08-04 | Bestätigt | Needham | Buy |
2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2020-05-05 | Bestätigt | Needham | Buy |
2020-02-19 | Eingeleitet | Needham | Buy |
2020-01-08 | Eingeleitet | SunTrust | Buy |
2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
2018-11-12 | Eingeleitet | BofA/Merrill | Buy |
2018-11-12 | Eingeleitet | Canaccord Genuity | Buy |
2018-11-12 | Eingeleitet | JMP Securities | Mkt Outperform |
2018-11-12 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Si Bone Inc Aktie (SIBN) Neueste Nachrichten
Proficio Capital Partners LLC Makes New $155,000 Investment in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry? - Simply Wall St
When the Price of (SIBN) Talks, People Listen - news.stocktradersdaily.com
Bank of New York Mellon Corp Sells 904 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Short Interest in SI-BONE, Inc. (NASDAQ:SIBN) Grows By 17.8% - Defense World
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) versus SI-BONE (NASDAQ:SIBN) - Defense World
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Indo-Asian News Service-THERADAPTIVE WELCOMES JEFFREY W. DUNN TO ITS BOARD OF DIRECTORS - IANS India Pvt Ltd
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga India
Proficio Capital Partners LLC Takes Position in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
(SIBN) Investment Analysis - Stock Traders Daily
SI-BONE’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Rhumbline Advisers - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by New York State Common Retirement Fund - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Receives $24.50 Average Target Price from Analysts - Defense World
VELA Investment Management LLC Boosts Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
SI-BONE (NASDAQ:SIBN) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
SI-BONE (NASDAQ:SIBN) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Truist Financial Reiterates "Buy" Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
SI-BONE (NASDAQ:SIBN) Hits New 1-Year High on Analyst Upgrade - MarketBeat
Cantor Fitzgerald Reiterates "Overweight" Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
SI-BONE FY2025 EPS Estimate Decreased by Cantor Fitzgerald - MarketBeat
SI-BONE (NASDAQ:SIBN) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
SI-BONE (NASDAQ:SIBN) Sets New 12-Month High Following Analyst Upgrade - Defense World
SI-BONE (NASDAQ:SIBN) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
SI-Bone price target raised to $24 from $20 at Needham - Yahoo Finance
Nikon Metrology Europe Appoints President: People in the News: 2/26/25 | Business | Feb 2025 - Photonics.com
SI-BONE (NASDAQ:SIBN) Shares Gap Up Following Earnings Beat - Defense World
Expert Outlook: SI-BONE Through The Eyes Of 5 Analysts - Benzinga
SI-BONE, Inc. (NASDAQ:SIBN) Q4 2024 Earnings Call Transcript - MSN
SI-Bone’s Strong Financial Performance and Promising Outlook Justifies Buy Rating and Raised Price Target - TipRanks
Cantor Fitzgerald maintains SI-BONE stock overweight with $25 target - Investing.com
Cantor Fitzgerald maintains SI-BONE stock overweight with $25 target By Investing.com - Investing.com South Africa
Earnings call transcript: Si-Bone Q4 2024 beats EPS forecast, stock rises - Investing.com Australia
SI-Bone price target raised to $22 from $18 at Truist - TipRanks
Needham raises SI-BONE stock target to $24 on strong guidance By Investing.com - Investing.com South Africa
Needham raises SI-BONE stock target to $24 on strong guidance - Investing.com India
SI-BONE worldwide revenue increases 26% to USD 49M in Q4 2024 - Medical Buyer
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates - MSN
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance - The Manila Times
SI-BONE Inc (SIBN) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Positive EBITDA - Yahoo Finance
SI-Bone: Strong Financial Performance and Strategic Positioning Justify Buy Rating - TipRanks
Si-Bone: Q4 Earnings Snapshot - Huron Daily Tribune
SI-BONE, Inc. Reports Record Growth and Positive EBITDA - TipRanks
Finanzdaten der Si Bone Inc-Aktie (SIBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):